EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting SMPDL3B to Ameliorate Radiation- and Cisplatin-Induced Renal Toxicity

Anis Ahmad iD, Shamroop Kumar Mallela, Saba Ansari, Mohammed Alnukhali, Sandra Merscher iD, Alla Mitrofanova iD, Youssef H Zeidan, Alan Pollack, Alessia Fornoni, Brian Marples iD

Cells · 22.01.2026 · 15 (2) · 205

DOI: 10.3390/cells15020205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 22.01.2026. Verfasst von Anis Ahmad und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL 33136, USA. Hauptthemen laut MEDLINE: Cisplatin, Sphingomyelin Phosphodiesterase, Kidney. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health/National Cancer Institute Physical Sciences-Oncology Network Award, Live Like Bella Pediatric Cancer Research Initiative, Live Like Bella Pediatric Cancer Research Initiative Program of the Florida Department of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kidney toxicity remains a major dose-limiting complication of radiation therapy and platinum-based chemotherapy, yet the molecular determinants of renal susceptibility and resilience to these genotoxic treatments are incompletely understood. Podocytes are particularly vulnerable to such insults, and emerging evidence implicates lipid dysregulation in podocyte injury. This study investigated the role of sphingomyelin phosphodiesterase acid-like 3B (SMPDL3B), a podocyte-enriched lipid-modulating enzyme, in radiation- and cisplatin-induced nephrotoxicity. Using a doxycycline-inducible, podocyte-specific SMPDL3B transgenic mouse model, renal injury was assessed following focal kidney irradiation, cisplatin administration, or their combination through functional assays, histopathology, ultrastructural analysis, immunofluorescence, and targeted lipidomics. Combined radiation and cisplatin exposure markedly reduced podocyte SMPDL3B expression, accompanied by podocyte depletion, glomerular basement membrane remodeling, proteinuria, and impaired renal function. These structural and functional abnormalities were associated with the selective accumulation of long-chain ceramide-1-phosphate species. In contrast, podocyte-specific induction of SMPDL3B preserved glomerular architecture, maintained renal function, and prevented pathological ceramide-1-phosphate elevation. Collectively, these findings identify SMPDL3B as a key regulator of podocyte stability and lipid homeostasis during chemoradiation stress. Enhancing SMPDL3B activity may represent a mechanistically grounded strategy to mitigate treatment-induced kidney injury while preserving anticancer efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinSphingomyelin PhosphodiesteraseKidneyAnimalsPodocytesMiceMice, TransgenicCeramides

Stichwörter der Autor:innen

SMPDL3Bceramide-1-phosphatecisplatinglomerular basement membranelipid metabolismnephrotoxicitypodocyte injuryradiation nephropathy

Substanzen

CisplatinSphingomyelin PhosphodiesteraseCeramides

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL 33136, USA.
  • Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Katz Family Division of Nephrology and Hypertension, Department of Medicine, and Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Department of Radiation Oncology Baptist Health, Lynn Cancer Institute, Boca Raton, FL 33437, USA.
  • Department of Radiation Oncology, University of Rochester Medical Center, 601 Elmwood Ave. Box 647, Rochester, NY 14642, USA.

ORCID-Profile: Anis Ahmad, Sandra Merscher, Alla Mitrofanova, Brian Marples

Förderung

  • National Institutes of Health/National Cancer Institute Physical Sciences-Oncology Network Award
  • Live Like Bella Pediatric Cancer Research Initiative
  • Live Like Bella Pediatric Cancer Research Initiative Program of the Florida Department of Health
  • U.S. Department of Defense Congressionally Directed Medical Research Kidney Cancer Research Programs
  • University of Miami Sylvester Comprehensive Cancer Center Developmental Stanley J. Glaser Foundation Grant
  • Sylvester Tumor Biology Intraprogrammatic Award
  • Women's Cancer Association Award
  • Veterans Administration Merit Review Award

Zitieren

APA

Ahmad, A., Mallela, S. K., Ansari, S., Alnukhali, M., Merscher, S., Mitrofanova, A., Zeidan, Y. H., Pollack, A., Fornoni, A., & Marples, B. (2026). Targeting SMPDL3B to Ameliorate Radiation- and Cisplatin-Induced Renal Toxicity. Cells, 15(2), 205. https://doi.org/10.3390/cells15020205

Vancouver

Ahmad A, Mallela SK, Ansari S, Alnukhali M, Merscher S, Mitrofanova A, et al. Targeting SMPDL3B to Ameliorate Radiation- and Cisplatin-Induced Renal Toxicity. Cells. 2026;15(2):205. doi:10.3390/cells15020205

BibTeX
@article{Ahmad2026,
  author = {Ahmad, Anis and Mallela, Shamroop Kumar and Ansari, Saba and Alnukhali, Mohammed and Merscher, Sandra and Mitrofanova, Alla and Zeidan, Youssef H and Pollack, Alan and Fornoni, Alessia and Marples, Brian},
  title = {Targeting SMPDL3B to Ameliorate Radiation- and Cisplatin-Induced Renal Toxicity},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {2},
  pages = {205},
  doi = {10.3390/cells15020205}
}
Kostenlos starten →